$1.2 Billion From U.S. to Drugmaker to Pursue Coronavirus Vaccine
The deal with AstraZeneca is the fourth and by far the largest vaccine research agreement that the department has disclosed. The money will pay for a Phase 3 clinical trial of a potential vaccine in the United States this summer with about 30,000 volunteers. The H.H.S. statement said the agency and AstraZeneca “are collaborating to…